PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24525736-5	2014	Treatment of hepatoma cells with salubrinal, an inhibitor of eIF2alpha dephosphorylation, enhances TRAIL-induced eIF2alpha phosphorylation, CCAAT/enhancer-binding protein homologous protein (CHOP) expression and caspase activation.	salubrinal	33-43	TNF superfamily member 10	Homo sapiens	99-104	
24525736-6	2014	Salubrinal enhances TRAIL-induced apoptosis, which could be abrogated by caspase inhibitor.	salubrinal	0-10	TNF superfamily member 10	Homo sapiens	20-25	
24525736-8	2014	By contrast, overexpression of phosphodeficient eIF2alpha (S51A) abrogates the stimulation of TRAIL-induced apoptosis by salubrinal.	salubrinal	121-131	TNF superfamily member 10	Homo sapiens	94-99	
24525736-10	2014	Furthermore, the sensitization of hepatoma cells to TRAIL by salubrinal is dependent on CHOP.	salubrinal	61-71	TNF superfamily member 10	Homo sapiens	52-57	
24525736-11	2014	Knockdown of CHOP abrogates the stimulation of TRAIL-induced caspase activation and apoptosis by salubrinal.	salubrinal	97-107	TNF superfamily member 10	Homo sapiens	47-52	
24525736-13	2014	Bim knockdown blunts the stimulatory effect of salubrinal on TRAIL-induced apoptosis.	salubrinal	47-57	TNF superfamily member 10	Homo sapiens	61-66	
21660448-10	2012	Furthermore, DMF-mediated sensitization of HCC cells to TRAIL was reduced by administration of a blocking antibody or small interfering RNAs for DR5, salubrinal, an inhibitor of ER stress, and the small interfering RNAs for CHOP.	salubrinal	150-160	TNF superfamily member 10	Homo sapiens	56-61